Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Tel Aviv - Delayed Quote ILA

InterCure Ltd. (INCR.TA)

Compare
560.00
-9.60
(-1.69%)
At close: February 27 at 5:24:57 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.
NameTitlePayExercisedYear Born
Mr. Alexander Rabinovich CEO & Chairman 728k -- 1971
Mr. Amos Cohen Chief Financial Officer 1.13M -- 1979
Einat Zehavi Vice President of Sales 859k -- --
Itai Kabiljo General Counsel -- -- --

InterCure Ltd.

85 Medinat ha-Yehudim Street
Herzliya, 4676670
Israel
972 7 746 05012 https://www.intercure.co
Sector: 
Healthcare
Full Time Employees: 
270

Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Corporate Governance

InterCure Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.